Almadin, Celso .
HRN: 25-46-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2024
CO-AMOXICLAV 625MG (TAB)
07/16/2024
07/20/2024
PER OREM
1 Tab
TID
CAP LR
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes